Results 91 to 100 of about 780 (156)
BMC Infectious DiseasesBackground Azvudine has clinical benefits and acceptable safety against COVID-19, including in patients with comorbidities, but there is a lack of available data for its use in older adult patients.
Zhiguo Zhou +5 more
doaj +1 more source
Azvudine (FNC): a promising clinical candidate for COVID-19 treatment [PDF]
Signal Transduction and Targeted Therapy, 2020 Yu, Bin, Chang, Junbiao
openaire +2 more sources
A Pragmatic Review of COVID-19 Management: Therapeutic Approaches, Challenges, and Recommendations [PDF]
The coronavirus disease 2019 (COVID-19), caused by the novel RNA virus SARS-CoV-2, was declared a global pandemic on 11 March 2020. Its rapid worldwide transmission highlighted the urgent need for effective clinical management strategies.
Linisha.N.M +4 more
core +1 more source
Review of COVID-19 Therapeutics by Mechanism: From Discovery to Approval [PDF]
The global research and pharmaceutical community rapidly mobilized to develop treatments for coronavirus disease 2019 (COVID-19). Existing treatments have been repurposed and new drugs have emerged.
Cho, SK +4 more
core +1 more source
Real-world data-driven early warning system for risk-stratified liver injury in hospitalized COVID-19 patients—Machine learning models for clinical decision support [PDF]
ObjectiveTo develop and validate a real-world evidence-driven early warning system for the risk-stratified prediction of coronavirus disease 2019 (COVID-19)-associated hepatic dysfunction in hospitalized patients, leveraging interpretable machine ...
Feng Lv +9 more
core +1 more source
Risk Factors and Nomogram Prediction Model for Healthcare-Associated Infections (HAIs) in COVID-19 Patients [PDF]
Zhanjie Li,1,* Jian Li,2,* Chuanlong Zhu,3 Shengyuan Jiao1,2 1Department of Infection Control, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, People’s Republic of China; 2Department of Disease Prevention ...
Jiao S, Li J, Li Z, Zhu C
core +1 more source
Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir for COVID-19: Considerations for Daily Practice [PDF]
Cardiovascular disease is associated with progression to severe COVID-19 and patients with the condition are among those in whom early antiviral therapy should be warranted.
Di Lenarda A. +4 more
core +1 more source
The first Chinese oral anti-COVID-19 drug Azvudine launched
The Innovation, 2022 Bin Yu, Junbiao Chang
openaire +2 more sources
Acta Pharmaceutica Sinica BThymus is the important immune organ, responsible for T cell development and differentiation. The lower circulating T counts have been observed in patients who died from COVID-19 compared with survivors. Azvudine, also known as FNC, is a thymus-homing anti-SARS-CoV-2 drug in treating COVID-19 patients.
Ning Sheng +7 more
openaire +3 more sources